Log in

NASDAQ:IMAC - IMAC Stock Price, Forecast & News

-0.08 (-6.72 %)
(As of 01/28/2020 01:54 AM ET)
Today's Range
Now: $1.11
50-Day Range
MA: $1.49
52-Week Range
Now: $1.11
Volume65,606 shs
Average Volume190,324 shs
Market Capitalization$9.49 million
P/E RatioN/A
Dividend YieldN/A
IMAC Holdings, Inc. operates a chain of integrated medicine and chiropractic regeneration centers. The company's outpatient clinics provide regenerative, orthopedic, and minimally invasive procedures and therapies to patients with back pain, knee pain, joint pain, ligament and tendon damage, and other related soft tissue conditions. As of September 17, 2018, it had 11 clinics, including 6 owned and 5 managed clinics in Kentucky, Missouri, and Tennessee, the United States. The company was founded in 2000 and is based in Brentwood, Tennessee.

Industry, Sector and Symbol

Industry Specialty outpatient clinics, not elsewhere classified
Current SymbolNASDAQ:IMAC



Sales & Book Value

Annual Sales$6.70 million


Net Income$-3,050,000.00


Market Cap$9.49 million
Next Earnings Date2/13/2020 (Estimated)
OptionableNot Optionable

Receive IMAC News and Ratings via Email

Sign-up to receive the latest news and ratings for IMAC and its competitors with MarketBeat's FREE daily newsletter.

IMAC (NASDAQ:IMAC) Frequently Asked Questions

What is IMAC's stock symbol?

IMAC trades on the NASDAQ under the ticker symbol "IMAC."

How were IMAC's earnings last quarter?

IMAC Holdings Inc (NASDAQ:IMAC) released its quarterly earnings results on Thursday, November, 14th. The company reported ($0.19) earnings per share for the quarter, missing the consensus estimate of ($0.02) by $0.17. The firm earned $4.36 million during the quarter, compared to the consensus estimate of $3.97 million. IMAC had a negative return on equity of 114.16% and a negative net margin of 41.07%. View IMAC's Earnings History.

When is IMAC's next earnings date?

IMAC is scheduled to release their next quarterly earnings announcement on Thursday, February 13th 2020. View Earnings Estimates for IMAC.

What is the consensus analysts' recommendation for IMAC?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for IMAC in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for IMAC.

Has IMAC been receiving favorable news coverage?

News coverage about IMAC stock has been trending somewhat negative recently, according to InfoTrie. InfoTrie identifies positive and negative media coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. IMAC earned a news impact score of -1.4 on InfoTrie's scale. They also gave headlines about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the company's share price in the near term. View News Stories for IMAC.

Are investors shorting IMAC?

IMAC saw a drop in short interest in the month of January. As of January 15th, there was short interest totalling 14,200 shares, a drop of 57.1% from the December 31st total of 33,100 shares. Based on an average trading volume of 65,400 shares, the short-interest ratio is presently 0.2 days. Approximately 0.4% of the company's stock are short sold. View IMAC's Current Options Chain.

Who are some of IMAC's key competitors?

Some companies that are related to IMAC include Acadia Healthcare (ACHC), BioTelemetry (BEAT), Hanger (HNGR), Biocorrx (BICX) and AAC (AAC).

What other stocks do shareholders of IMAC own?

Who are IMAC's key executives?

IMAC's management team includes the folowing people:
  • Mr. Jeffrey S. Ervin M.B.A., CEO & Director (Age 41)
  • Mr. D. Anthony Bond CPA, Chief Financial Officer (Age 57)
  • Dr. Matthew C. Wallis, COO & Director (Age 45)
  • Mr. Jeff Ervin, Chief Exec. Officer
  • Dr. Ian A. White Ph.D., Chief Scientific Officer (Age 44)

When did IMAC IPO?

(IMAC) raised $4 million in an IPO on the week of February 11th 2019. The company issued 900,000 shares at $5.00 per share. Dawson James Securities and Cuttone served as the underwriters for the IPO.

How do I buy shares of IMAC?

Shares of IMAC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is IMAC's stock price today?

One share of IMAC stock can currently be purchased for approximately $1.11.

How big of a company is IMAC?

IMAC has a market capitalization of $9.49 million and generates $6.70 million in revenue each year. View Additional Information About IMAC.

What is IMAC's official website?

The official website for IMAC is http://www.imacregeneration.com/.

How can I contact IMAC?

IMAC's mailing address is 1605 WESTGATE CIRCLE, BRENTWOOD TN, 37027. The company can be reached via phone at 844-266-4622 or via email at [email protected]

MarketBeat Community Rating for IMAC (NASDAQ IMAC)

Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  57 (Vote Outperform)
Underperform Votes:  77 (Vote Underperform)
Total Votes:  134
MarketBeat's community ratings are surveys of what our community members think about IMAC and other stocks. Vote "Outperform" if you believe IMAC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IMAC will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/28/2020 by MarketBeat.com Staff

Featured Article: What is Liquidity?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel